Advanced glycation end products in degenerative nucleus pulposus with diabetes

Journal of Orthopaedic Research

Volumn 32, Issue 2, 2014, Pages 238-244

  Tsai, Tsung Ting ^a,b   Ho, Natalie Yi Ju ^b   Lin, Ying Ting ^b   Lai, Po Liang ^b   Fu, Tsai Sheng ^b   Niu, Chi Chien ^b   Chen, Lih Huei ^b   Chen, Wen Jer ^b   Pang, Jong Hwei S ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

advanced glycation end products; diabetes mellitus; disc degeneration; glucose

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GELATINASE A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL ISOLATION; COCCYGEAL BONE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK DEGENERATION; MALE; NONHUMAN; NUCLEUS PULPOSUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ADVANCED GLYCATION END PRODUCTS; DIABETES MELLITUS; DISC DEGENERATION; GLUCOSE;

ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; MALE; MATRIX METALLOPROTEINASE 2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC;

EID: 84890570673     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22508     Document Type: Article

References (24)

1. Maniadakis N, Gray A., 2000. The economic burden of back pain in the UK. Pain 84: 95-103.
2. Le Maitre CL, Freemont AJ, Hoyland JA., 2004. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 204: 47-54.
3. Crean JK, Roberts S, Jaffray DC, et al. 1997. Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis. Spine (Phila Pa 1976) 22: 2877-2884.
4. Silberberg R., 1986. The skeleton in diabetes mellitus: a review of the literature. Diabetes Res 3: 329-338.
5. Johnson WE, Stephan S, Roberts S., 2008. The influence of serum, glucose and oxygen on intervertebral disc cell growth in vitro: implications for degenerative disc disease. Arthritis Res Ther 10: R46.
6. Sakellaridis N., 2006. The influence of diabetes mellitus on lumbar intervertebral disk herniation. Surg Neurol 66: 152-154.
7. Anekstein Y, Smorgick Y, Lotan R, et al. 2010. Diabetes mellitus as a risk factor for the development of lumbar spinal stenosis. Isr Med Assoc J 12: 16-20.
8. Peppa M, Uribarri J, Vlassara H., 2003. Glucose, advanced glycation end products, and diabetes complications: what is new and what works. Clin Diabetes 21: 186-187.
9. Goh SY, Cooper ME., 2008. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93: 1143-1152.
10. Tsai TT, Lai PL, Liao JC, et al. 2013. Increased periostin gene expression in degenerative intervertebral disc cells. Spine J 13: 289-298.
11. Klein R., 1995. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18: 258-268.
12. Vogt MT, Rubin D, Valentin RS, et al. 1998. Lumbar olisthesis and lower back symptoms in elderly white women. The Study of Osteoporotic Fractures. Spine (Phila Pa 1976) 23: 2640-2647.
13. Robinson D, Mirovsky Y, Halperin N, et al. 1998. Changes in proteoglycans of intervertebral disc in diabetic patients. A possible cause of increased back pain. Spine (Phila Pa 1976) 23: 849-855, discussion 856.
14. Ziv I, Moskowitz RW, Kraise I, et al. 1992. Physicochemical properties of the aging and diabetic sand rat intervertebral disc. J Orthop Res 10: 205-210.
15. Won HY, Park JB, Park EY, et al. 2009. Effect of hyperglycemia on apoptosis of notochordal cells and intervertebral disc degeneration in diabetic rats. J Neurosurg Spine 11: 741-748.
16. Jiang L, Zhang X, Zheng X, et al. 2013. Apoptosis, senescence, and autophagy in rat nucleus pulposus cells: implications for diabetic intervertebral disc degeneration. J Orthop Res 31: 692-702.
17. Tsuru M, Nagata K, Jimi A, et al. 2002. Effect of AGEs on human disc herniation: intervertebral disc hernia is also effected by AGEs. Kurume Med J 49: 7-13.
18. Yokosuka K, Park JS, Jimbo K, et al. 2006. Advanced glycation end-products downregulating intervertebral disc cell production of proteoglycans in vitro. J Neurosurg Spine 5: 324-329.
19. Singh R, Barden A, Mori T, et al. 2001. Advanced glycation end-products: a review. Diabetologia 44: 129-146.
20. Brownlee M, Cerami A, Vlassara H., 1988. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321.
21. Wagner DR, Reiser KM, Lotz JC., 2006. Glycation increases human annulus fibrosus stiffness in both experimental measurements and theoretical predictions. J Biomech 39: 1021-1029.
22. Kislinger T, Fu C, Huber B, et al. 1999. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274: 31740-31749.
23. Death AK, Fisher EJ, McGrath KC, et al. 2003. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 168: 263-269.
24. Aimes RT, Quigley JP., 1995. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 270: 5872-5876.